EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploration of alpha-glucosidase inhibitors: A comprehensive in silico approach targeting a large set of triazole derivatives

Oussama Abchir, Meriem Khedraoui, Imane Yamari, Hassan Nour, Abdelkbir Errougui, Abdelouahid Samadi iD, Samir Chtita iD

PLOS ONE · 06.09.2024 · 19 (9) · e0308308

DOI: 10.1371/journal.pone.0308308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 06.09.2024. Verfasst von Oussama Abchir und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Analytical and Molecular Chemistry, Chemistry, Research, and Development, Sciences and Applications, Faculty of Sciences Ben M'Sik, Has…. Hauptthemen laut MEDLINE: Glycoside Hydrolase Inhibitors, Triazoles, Molecular Docking Simulation, alpha-Glucosidases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United Arab Emirates University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The increasing prevalence of diabetes and the side effects associated with current medications necessitate the development of novel candidate drugs targeting alpha-glucosidase as a potential treatment option.

Methods

This study employed computer-aided drug design techniques to identify potential alpha-glucosidase inhibitors from the PubChem database. Molecular docking was used to evaluate 81,197 compounds, narrowing the set for further analysis and providing insights into ligand-target interactions. An ADMET study assessed the pharmacokinetic properties of these compounds, including absorption, distribution, metabolism, excretion, and toxicity. Molecular dynamics simulations validated the docking results.

Results

9 compounds were identified as potential candidate drugs based on their ability to form stable complexes with alpha-glucosidase and their favorable pharmacokinetic profiles, three of these compounds were subjected to the molecular dynamics, which showed stability throughout the entire 100 ns simulation.

Conclusion

These findings suggest promising new alpha-glucosidase inhibitors for diabetes treatment. Further validation through in vitro and in vivo studies is recommended to confirm their efficacy and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycoside Hydrolase InhibitorsTriazolesMolecular Docking Simulationalpha-GlucosidasesMolecular Dynamics SimulationHumansComputer SimulationDrug Design

Substanzen

Glycoside Hydrolase InhibitorsTriazolesalpha-Glucosidases

Autor:innen und Institutionen

  • Laboratory of Analytical and Molecular Chemistry, Chemistry, Research, and Development, Sciences and Applications, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, Sidi Othman, Casablanca, Morocco.
  • Department of Chemistry, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates.

ORCID-Profile: Abdelouahid Samadi, Samir Chtita

Förderung

  • United Arab Emirates University

Zitieren

APA

Abchir, O., Khedraoui, M., Yamari, I., Nour, H., Errougui, A., Samadi, A., & Chtita, S. (2024). Exploration of alpha-glucosidase inhibitors: A comprehensive in silico approach targeting a large set of triazole derivatives. PLOS ONE, 19(9), e0308308. https://doi.org/10.1371/journal.pone.0308308

Vancouver

Abchir O, Khedraoui M, Yamari I, Nour H, Errougui A, Samadi A, et al. Exploration of alpha-glucosidase inhibitors: A comprehensive in silico approach targeting a large set of triazole derivatives. PLOS ONE. 2024;19(9):e0308308. doi:10.1371/journal.pone.0308308

BibTeX
@article{Abchir2024,
  author = {Abchir, Oussama and Khedraoui, Meriem and Yamari, Imane and Nour, Hassan and Errougui, Abdelkbir and Samadi, Abdelouahid and Chtita, Samir},
  title = {Exploration of alpha-glucosidase inhibitors: A comprehensive in silico approach targeting a large set of triazole derivatives},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {9},
  pages = {e0308308},
  doi = {10.1371/journal.pone.0308308}
}
Kostenlos starten →